PALATIN TECHNOLOGIES, INC. Cost of Revenue
PALATIN TECHNOLOGIES, INC. (PTN) reported Cost of Revenue of $97.64 thousand for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2024-09-30
- PALATIN TECHNOLOGIES, INC. cost of revenue for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of revenue for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of revenue for the quarter ending 2023-12-31 was $97.64K, a 1.08% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of revenue for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. cost of revenue for fiscal 2024 was $97.64K, a 76.67% decline from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. cost of revenue for fiscal 2023 was $418.47K, a 92.37% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. cost of revenue for fiscal 2022 was $217.53K, a 47.14% increase from fiscal 2021.
- PALATIN TECHNOLOGIES, INC. cost of revenue for fiscal 2021 was $147.84K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $97.64K derived: sum of 3 quarters · filed 2024-09-30 | $97.64K 10-K · filed 2024-09-30 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $97.64K derived: sum of 2 quarters · filed 2024-05-15 | $97.64K 10-Q · filed 2024-05-15 | $201.67K derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-12-31 | $97.64K 10-Q · filed 2024-02-14 | $97.64K 10-Q · filed 2024-02-14 | $201.67K derived: sum of 3 quarters · filed 2024-09-30 | $330.90K derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $104.03K derived: sum of 2 quarters · filed 2024-09-30 | $233.27K derived: sum of 3 quarters · filed 2024-09-30 | $331.97K derived: sum of 4 quarters · filed 2024-09-30 |
| 2023-06-30 | $104.03K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $233.27K derived: sum of 2 quarters · filed 2024-09-30 | $331.97K derived: sum of 3 quarters · filed 2024-09-30 | $418.47K 10-K · filed 2024-09-30 |
| 2023-03-31 | $129.24K 10-Q · filed 2024-05-15 | $227.94K derived: sum of 2 quarters · filed 2024-05-15 | $314.44K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $98.71K 10-Q · filed 2024-02-14 | $185.20K 10-Q · filed 2024-02-14 | ||
| 2022-09-30 | $86.50K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $217.53K 10-K · filed 2022-09-22 | |||
| 2021-09-30 | $53.93K 10-Q · filed 2022-11-14 | $91.73K derived: sum of 2 quarters · filed 2022-11-14 | $147.17K derived: sum of 3 quarters · filed 2022-11-14 | $176.57K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $37.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $93.24K derived: sum of 2 quarters · filed 2022-09-22 | $122.64K derived: sum of 3 quarters · filed 2022-09-22 | $147.84K 10-K · filed 2022-09-22 |
| 2021-03-31 | $55.44K 10-Q · filed 2021-05-14 | $84.84K derived: sum of 2 quarters · filed 2021-05-14 | $110.04K 10-Q · filed 2021-05-14 | $110.04K derived: sum of 4 quarters · filed 2021-09-28 |
| 2020-12-31 | $29.40K 10-Q · filed 2021-02-16 | $54.60K 10-Q · filed 2021-02-16 | $54.60K derived: sum of 3 quarters · filed 2021-09-28 | $54.60K derived: sum of 4 quarters · filed 2021-09-28 |
| 2020-09-30 | $25.20K 10-Q · filed 2020-11-16 | $25.20K derived: sum of 2 quarters · filed 2021-09-28 | $25.20K derived: sum of 3 quarters · filed 2021-09-28 | $25.20K derived: sum of 4 quarters · filed 2021-09-28 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $0.00 derived: sum of 2 quarters · filed 2021-09-28 | $0.00 derived: sum of 3 quarters · filed 2021-09-28 | $0.00 10-K · filed 2021-09-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |